Li Mao
Chaigoubu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
MicroRNA-200a activates Nrf2 signaling to protect osteoblasts from dexamethasone.
Journal: Oncotarget
Published: May 23, 2017
Insulin resistance in vitamin D-deficient mice is alleviated by n-acetylcysteine.
Journal: Oncotarget
Published: May 07, 2017
Vitamin D deficiency causes insulin resistance by provoking oxidative stress in hepatocytes.
Journal: Oncotarget
Published: April 21, 2017
Assessment of GSK1904529A as a promising anti-osteosarcoma agent.
Journal: Oncotarget
Published: April 18, 2017
PP2A catalytic subunit silence by microRNA-429 activates AMPK and protects osteoblastic cells from dexamethasone.
Journal: Biochemical and biophysical research communications
Published: March 25, 2017
Targeted activation of AMPK by GSK621 ameliorates H2O2-induced damages in osteoblasts.
Journal: Oncotarget
Published: December 01, 2016
Icariside II activates EGFR-Akt-Nrf2 signaling and protects osteoblasts from dexamethasone.
Journal: Oncotarget
Published: November 07, 2016
Activating AMP-activated protein kinase by an α1 selective activator compound 13 attenuates dexamethasone-induced osteoblast cell death.
Journal: Biochemical and biophysical research communications
Published: January 18, 2016
K6PC-5, a novel sphingosine kinase 1 (SphK1) activator, alleviates dexamethasone-induced damages to osteoblasts through activating SphK1-Akt signaling.
Journal: Biochemical and biophysical research communications
Published: January 23, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026